Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-20

Clinical Trial Update: Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism [NA]

View source ↗

Summary

A clinical trial is evaluating adrenal artery ablation in combination with spironolactone for patients with primary aldosteronism; recruitment is ongoing. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Third Military Medical University | Conditions: Primary Aldosteronism, Hypertension | NA | Status: RECRUITING